Catalyst Wire Dossier Catalyst Wire Dossier

Vorapaxar (SCH 530348)

vorapaxar · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vorapaxar (SCH 530348), covering 2014-07-14 to 2014-07-14. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183) [Phase 3]

See pricing